|View printer-friendly version|
|Array BioPharma to Present at the UBS Global Life Sciences Conference|
BOULDER, Colo.--(BUSINESS WIRE)--Sept. 16, 2008--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Global Life Sciences Conference on September 24 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: UBS Global Life Sciences Conference
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases and pain. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.